Skin cells turned cancer-killing stem cells hunt down and destroy the deadly remnants inevitably left behind when a brain tumor is surgically removed
In a first for medical science, University of North Carolina at Chapel Hill pharmacy researchers turn skin cells into cancer-hunting stem cells that destroy brain tumors known as glioblastoma – a discovery that can offer, for the first time in more than 30 years, a new and more effective treatment for the disease.
The technique, reported in Nature Communications, builds upon the newest version of the Nobel Prize-winning technology from 2007, which allowed researchers to turn skin cells into embryonic-like stem cells. Researchers hailed the possibilities for use in regenerative medicine and drug screening. Now, researchers have found a new use: killing brain cancer.
“Patients desperately need a better standard of care,” said Shawn Hingtgen, Ph.D., an assistant professor in the UNC Eshelman School of Pharmacy and member of the Lineberger Comprehensive Care Center, who led the study.
The survival rate beyond two years for a patient with a glioblastoma is 30 percent because it is so difficult to treat. Even if a surgeon removes most of the tumor, it’s nearly impossible to get the invasive, cancerous tendrils that spread deeper into the brain and inevitably the remnants grow back. Most patients die within a year and a half of their diagnosis.
Hingtgen and his team want to improve those statistics by developing a new personalized treatment for glioblastoma that starts with a patient’s own skin cells, with the goal of getting rid of the cancerous tendrils, effectively killing the glioblastoma.
In their work, Hingtgen and his team reprogram skin cells known as fibroblasts – which produce collagen and connective tissue — to become induced neural stem cells. Working with mice, Hingtgen’s team showed that these neural stem cells have an innate ability to move throughout the brain and home in on and kill any remaining cancer cells. The team also showed that these stem cells could be engineered to produce a tumor-killing protein, adding another blow to the cancer.
Depending on the type of tumor, the Hingtgen’s team increased survival time of the mice 160 to 220 percent. Next steps will focus on human stem cells and testing more effective anti-cancer drugs that can be loaded into the tumor-seeking neural stem cells.
“Our work represents the newest evolution of the stem-cell technology that won the Nobel Prize in 2012,” Hingtgen said. “We wanted to find out if these induced neural stem cells would home in on cancer cells and whether they could be used to deliver a therapeutic agent. This is the first time this direct reprogramming technology has been used to treat cancer.”
Learn more: UNC-Chapel Hill researchers make groundbreaking discovery, use skin cells to kill cancer
The Latest on: Induced neural stem cells
[google_news title=”” keyword=”induced neural stem cells” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Induced neural stem cells
- Accessible Cell Therapies for Alzheimer's and Parkinson's Diseaseon April 25, 2024 at 10:21 pm
Researchers have now potentially advanced the accessible personalized cell-based therapies for Alzheimer's and Parkinson's diseases.
- Stem cell transplants and survival rates on the rise across all racial and ethnic groupson April 25, 2024 at 7:00 am
The volume of hematopoietic cell transplants rose among all racial/ethnic groups, but grew faster among African Americans and Hispanics compared with non-Hispanic white individuals, mirroring changes ...
- Therapeutic potential of human umbilical cord-derived mesenchymal stem cells in Crohn’s diseaseon April 25, 2024 at 6:00 am
Whether human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) could heal luminal ulcers in Crohn’s disease.
- ASO Therapy Repairs Neurons from Timothy Syndrome Patientson April 24, 2024 at 5:00 pm
This rescued both delayed channel inactivation and the defect in depolarization-induced calcium elevation ... in vivo and in vitro stem cell model-based approach can identify strategies for reversing ...
- New device improves stem cell generation and chance for accessible Alzheimer's cell therapyon April 24, 2024 at 12:11 pm
Researchers in Sweden say they have improved on a technique for converting regular skin cells into neural stem cells—an advance that they say helps close the gap for accessible personalized cell-based ...
- Human Embryonic Stem Cells Market Latest Trends, Size, Key Players, Revenue, Growth, and Forecast 2024 to 2032on April 18, 2024 at 10:00 pm
Report Ocean recently added a research report on “Human Embryonic Stem Cells Market”. The report includes an extensive analysis of the market’s characteristics, COVID-19 impact, size and growth, ...
- Retinoblastoma Origins and Destinationson April 16, 2024 at 5:01 pm
For permission requests, please contact NEJM Reprints at [email protected] We and others identified retinoblastoma features that suggested that the tumors originate in long- and medium-wavelength cone ...
- TREEFROG PRESENTS DATA FROM THEIR PARKINSON'S CELL THERAPY PROGRAM AT THE AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETINGon April 15, 2024 at 12:30 am
TreeFrog Therapeutics reports on the first bioproduction of a cell therapy for Parkinson's Disease in a scalable bioreactor1 BORDEAUX, France, April 15, 2024 /PRNewswire/ -- TreeFrog Therapeutics, a ...
- How the inflamed brain becomes disconnected after a strokeon April 12, 2024 at 7:06 am
The findings, published last month in Cell Reports, describe in detail a new degenerative pathway that scientists can now try to disrupt. This could help stem the damage from ... but it's brutal on ...
- Research team discovers new way to generate human cartilageon April 10, 2024 at 11:49 am
University of Montana researchers and their partners have found a new method to generate human cartilage of the head and neck. Mark Grimes, a biology professor in UM's Division of Biological Sciences, ...
via Bing News